Targets of the Tumor Suppressor <i>miR-200</i> in Regulation of the Epithelial–Mesenchymal Transition in CancerMark J. Schliekelman, Samir Hanash, Dong Hoon Shin et al.|Cancer Research|2011Cited by 138
The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKLChristin Ungewiss, Don L. Gibbons, Zain H. Rizvi et al.|Scientific Reports|2016Cited by 74
Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal AntibodyDong Hoon Shin, Ho‐Young Lee|Molecular Cancer Therapeutics|2011Cited by 43
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancerDong Hoon Shin, Sang Soo Kim|Experimental & Molecular Medicine|2023Cited by 18
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancerDong Hoon Shin, Sang Soo Kim|Research Square|2023Cited by 1